Webinar: Unraveling the roles of copy number variants in tumorigenesis [Video]

Genomic analysis has provided valuable insights into the mechanisms of tumorigenesis in humans. Among the identified abnormalities, copy number variations (CNVs) have emerged as significant pathogenic variants and important biomarkers for early detection and follow-up.

Applied Biosystems™ OncoScan™ CNV assays have proven to be highly effective tools for CNV research in solid tumor samples. These assays demonstrate robust detection capabilities for loss of heterozygosity (LOH) and CNVs, which play crucial roles in cancer origination, progression, and metastasis. Moreover, OncoScan CNV assays offer the advantage of processing highly degraded and low‑quality samples, commonly encountered in solid tumor research.

During this webinar, speaker Xiaolan Fang, associate director of the cytogenomics and molecular pathology laboratories of the Henry Ford Health System, discusses the development and application of OncoScan CNV assays in a research setting. The focus is on deciphering molecular and cytogenetic mechanisms in representative types of solid tumors.

By attending this webinar, you will have the opportunity to:

Explore the evolution and development of cytogenetics and cytogenomics throughout history
Gain familiarity with the current tools and techniques used in cytogenetic research and analysis
Understand the unique advantages and benefits of OncoScan assays compared to other array/next-generation sequencing platforms for cytogenomic research

Acquire knowledge about the specific types of tumor research samples that can be effectively analyzed using OncoScan assay technology